Teng‐Kuang Yeh

机构：National Health Research Institutes · ORCID：0000-0001-5235-1636

发表论文 198 篇 · 总被引 4665 次 · h-index 37

代表论文

• Orally Bioavailable and Site-Selective Covalent STING Inhibitor Derived from a Macrocyclic Marine Diterpenoid (2025 · Journal of Medicinal Chemistry · 被引 23)
• CXCR4 antagonist-loaded nanoparticles reprogram the tumor microenvironment and enhance immunotherapy in hepatocellular carcinoma (2025 · Journal of Controlled Release · 被引 22)
• Development of Potent and Selective Inhibitors of Methylenetetrahydrofolate Dehydrogenase 2 for Targeting Acute Myeloid Leukemia: SAR, Structural Insights, and Biological Characterization (2024 · Journal of Medicinal Chemistry · 被引 9)
• Identification of PTGR2 inhibitors as a new therapeutic strategy for diabetes and obesity (2025 · EMBO Molecular Medicine · 被引 4)
• In vitro and in vivo efficacy of vancomycin against Elizabethkingia species and the impact of increased vancomycin MICs (2025 · Microbiology Spectrum · 被引 3)
• Structure-Based Design of Potent and Selective MerTK Inhibitors by Modulating the Conformation of αC Helix (2025 · Journal of Medicinal Chemistry · 被引 1)